Published protocols using BPC-157 and TB-500 in combination typically follow a loading phase of daily or every-other-day administration for 2-4 weeks, followed by reduced frequency for maintenance
Three approaches are common: Daily dosing gives you the most consistent AMPK activation and mitochondrial support
But, some patients might need more frequent doses
For most first-time users, topical at 1 to 2% delivers visible results without the regulatory complications around compounded injectables
ABSORPTION AND BIOAVAILABILITY Oral bioavailability: Unlike some peptides that are degraded by stomach acids, BPC-157 capsules have been found to remain stable when taken orally, allowing them to reach the target tissues effectively
Gene Expression Modulation : BPC 157 influences the expression of genes involved in cytoskeleton remodeling, healing, and cellular survival